Considerations for the discovery and development of 3-chymotrypsin-like cysteine protease inhibitors targeting SARS-CoV-2 infection
Koen Vandyck, Jérôme Deval
Topics & Concepts
ProteasesProteaseBiologyPotencyVirologyCoronavirusDrug discoveryVirusProtease inhibitor (pharmacology)PandemicSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)PharmacologyIn vitroEnzymeBioinformaticsMedicineDiseaseInfectious disease (medical specialty)Viral loadBiochemistryAntiretroviral therapyInternal medicineSARS-CoV-2 and COVID-19 ResearchSARS-CoV-2 detection and testingCOVID-19 Clinical Research Studies